INO

Inovio Pharmaceuticals (INO)

Inovio Pharmaceuticals Inc New

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	06 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/17	05 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/14	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/14	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/14	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/14	05 : 05	PR Newswire (US)	INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/14	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/05/01	21 : 00	PR Newswire (US)	INOVIO Reports Inducement Grants Under Inducement Plan	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/04/29	21 : 00	PR Newswire (US)	INOVIO to Participate in Upcoming Investor Conferences in May	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/04/29	21 : 00	PR Newswire (US)	INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/04/16	07 : 39	PR Newswire (US)	INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/03/27	07 : 28	PR Newswire (US)	INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/03/07	06 : 05	PR Newswire (US)	INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/03/06	21 : 00	PR Newswire (US)	Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/03/06	20 : 02	IH Market News	U.S. Stock Futures Gain Ahead of Economic Insights; Oil Prices Climb	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/02/21	22 : 00	PR Newswire (US)	INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/02/08	01 : 46	PR Newswire (US)	INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/02/02	22 : 00	PR Newswire (US)	INOVIO Reports Inducement Grant Under Inducement Plan	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/02/01	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/01/27	06 : 01	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:INO	Inovio Pharmaceuticals Inc New
2024/01/26	06 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INO	Inovio Pharmaceuticals Inc New